• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

COVID-19-related hospital policies not associated with delays in urgent open and closed fracture surgeries compared to pre-pandemic

byJake EngelandMichael Pratte
November 2, 2021
in Infectious Disease, Orthopedic Surgery, Public Health, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This retrospective cohort study demonstrated no association between the time-to-surgery benchmark of 24 hours for open fractures or closed pelvis/femur fractures requiring surgery during the COVID-19 pandemic compared to pre-pandemic.

Evidence Rating Level: 2 (Good)

Study Rundown: The COVID-19 pandemic has forced hospitals to reallocate resources, reduce operating room capacity, and shift protocols regarding clinical management strategies. These changes have raised concerns regarding delaying acute treatment for patients with a traumatic injury. This retrospective cohort study (secondary analysis of the PREP-IT trial) investigated whether COVID-19-related policies were associated with increased delays in urgent fracture surgery beyond national time-to-surgery benchmarks. The time-to-surgery benchmark for open fractures, hip fractures, and femoral shaft fractures is 24-hour from injury. This study enrolled 3598 patients from 20 sites across the U.S. and Canada, who presented with an open extremity fracture needing surgery or a closed lower extremity or pelvis fracture requiring surgery. The primary outcome was the proportion of these patients who had surgery within 24 hours of injury. March 13, 2020 was chosen as the threshold for when COVID-19-related hospital policies materialized. In the open fracture group, 30/1126 (2.7%) pre-COVID-19 patients compared to 24/609 (3.9%) patients during COVID-19 did not meet the 24-hour time-to-surgery benchmark; no association was found between admission during the pandemic and operating room delay (Odds ratio [OR]: 1.40 [95%: 0.77-2.55]; p= 0.28). In the closed fracture group, 244/1058 (23.1%) pre-COVID-19 patients compared to 163/805 (20.2%) COVID-19-era patients did not meet the 24-hour benchmark; no association was detected between admission during the pandemic and time-to-surgery beyond 24 hours (OR: 1.01 [95% CI: 0.74-1.37]; p= 0.97). Even in areas where the COVID-19 case rate was increased, there was no association detected between regional case rate and time-to-surgery delay for closed fractures (OR: 1.07 [95% CI: 0.70-1.64]; p= 0.76). Open fracture surgery delays were not evaluated on a regional basis. This study was limited by the low rate of cases who failed to meet open fracture surgery benchmarks; this restricted the ability to evaluate the association between regional COVID-19 cases and time-to-surgery for this cohort. Overall, this retrospective cohort study demonstrated that 24-hour time-to-surgery benchmarks for open and closed fractures were unaffected by COVID-19 hospital policies compared to pre-pandemic.

Click to read the study in JAMA Health Forum

Relevant Reading: The effects of a UK lockdown on orthopaedic trauma admissions and surgical cases

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

Tags: covidCOVID-19fracture
Previous Post

Empaglifozin reduces death in heart failure patients with preserved ejection fraction

Next Post

Systematic screening for atrial fibrillation may reduce morbidity and mortality in older patients

RelatedReports

Stem cell transplant may be effective in sickle cell disease
Chronic Disease

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

July 4, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Cardiology

Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination

June 30, 2022
#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
StudyGraphics

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

June 30, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Chronic Disease

2 Minute Medicine Rewind June 27, 2022

June 27, 2022
Next Post
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Systematic screening for atrial fibrillation may reduce morbidity and mortality in older patients

Poverty, preterm birth demonstrate additive effect on cognition

Phototherapy not associated with increased risk of childhood cancer

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Respiratory fluroquinolone treatment associated with increased short-term risk of sudden cardiac death compared to amoxicillin-based antibiotics

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
  • FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.